Dermira, Inc.
DERM
DERM was delisted on the 19th of February, 2020.
133 hedge funds and large institutions have $776M invested in Dermira, Inc. in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 26 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
162% more call options, than puts
Call options by funds: $14.9M | Put options by funds: $5.67M
139% more capital invested
Capital invested by funds: $325M → $776M (+$451M)
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
2% more funds holding
Funds holding: 131 → 133 (+2)
11% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.9M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$6.89M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$6M |
| 4 |
Millennium Management
New York
|
+$4.63M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.5M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$5.79M |
| 3 |
FAM
Fred Alger Management
New York
|
-$5.05M |
| 4 |
Renaissance Technologies
New York
|
-$4.18M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.98M |
DERM Hedge Fund Activity: Q4 2019 in Review
133 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q4 2019, worth a combined $776M — up 139% from $325M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new DERM positions and 26 closed out — a net gain of 4 holders — while 42 added to existing stakes and 47 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $16.9M. The largest seller was PFM Health Sciences, cutting an estimated $13.5M.
- 133 institutional investors held Dermira, Inc. (DERM) as of Q4 2019, up from 131 in Q3 2019.
- Funds reported $776M of Dermira, Inc. stock for Q4 2019, up 139% quarter-over-quarter.
- 30 funds opened new Dermira, Inc. positions in Q4 2019 and 26 closed out, a net change of +4 holders.
- The largest Dermira, Inc. buyer in Q4 2019 was Fidelity Investments, an estimated $16.9M added.
- The largest Dermira, Inc. seller in Q4 2019 was PFM Health Sciences, an estimated $13.5M sold.
Based on aggregated 13F filings for Q4 2019.